The Zacks Analyst Blog Novo Nordisk, The Coca-Cola, Wells Fargo and Star Group
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Beat the Market the Zacks Way: Verona, Visa, Starbucks in Focus
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key ...
Zacks Research Analysts Decrease Earnings Estimates for BURL
Equities research analysts at Zacks Research reduced their FY2025 earnings per share (EPS) estimates for shares of Burlington ...
Zacks Research Estimates AptarGroup’s Q3 Earnings (NYSE:ATR)
Equities research analysts at Zacks Research reduced their Q3 2025 earnings per share estimates for shares of AptarGroup in a ...
Canadian Natural Resources: Q4 Earnings Snapshot
On a per-share basis, the Calgary Alberta Canada, Alberta-based company said it had net income of 39 cents. Earnings, adjusted for non-recurring costs, were 66 cents per share. The results missed Wall ...
Zacks Investment Research on MSN1hOpinion
New Strong Buy Stocks for March 6th
List today: Molson Coors Beverage Company TAP: This beer and malt beverages company has seen the Zacks Consensus Estimate for ...
Zacks Investment Research on MSN2h
New Strong Sell Stocks for March 6th
List today: Artelo Biosciences, Inc. ARTL is a clinical stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 50.5% downward over the last 60 ...
Fate Therapeutics: Q4 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — Fate Therapeutics Inc. (FATE) on Wednesday reported a loss of $52.2 million in its fourth quarter. On a per-share basis, the San Diego-based company said it had a ...
10 Stocks Defy Market Optimism as Investor Caution Lingers
The stock market stood its ground on Wednesday, with all major indices eking out gains as President Donald Trump softened ...